Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengfa Tablets (生发片) is a Traditional Chinese Medicine (TCM) pharmaceutical product developed and manufactured by Shanxi Zhendong Pharmacy for the treatment of hair loss. The formulation is designed to nourish the liver and kidneys, replenish vital essence, and enrich the blood, addressing the underlying physiological imbalances that lead to hair thinning and loss according to TCM theory. It is indicated for conditions such as alopecia areata and seborrheic alopecia (male pattern baldness). The tablets contain a combination of herbal extracts, including *Polygonum multiflorum* (He Shou Wu), *Rehmannia glutinosa*, and *Angelica sinensis*, and are administered orally. It is currently marketed in China as an approved treatment for hair regrowth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shengfa Tablets.